The recommendations drew heavily from the PIANO study, which tracked 2,268 pregnant women with IBD and 1,702 live births. The consortium used formal Grading of Recommendations Assessment, Development, ...

The new campaign aims to empower patients to take dual control of disease management and life aspirations by striving for ...

With a fresh endorsement from the FDA, Johnson & Johnson has rounded out Tremfya’s presence in inflammatory bowel disease ...

Patients with inflammatory bowel disease had a higher risk for venous thromboembolism after surgery for colorectal cancer than those without IBD, according to a Danish cohort study published in The ...

A Spanish trial finds similar sustained IBD clinical remission rates 1-year post-withdrawal vs maintenance of anti-TNF ...

Johnson & Johnson has launched its "Dual control" campaign in Asia Pacific, aiming to empower patients with inflammatory bowel disease (IBD) to manage their condition while pursuing life goals.

LONDON - About 5% of the world’s population, including an estimated 3.1 million adults in the U.S., suffer from inflammatory bowel disease (IBD) – the umbrella term for Crohn’s disease and ulcerative ...

The 28-year-old defender is now supporting IBD research by the Royal Devon University Healthcare NHS Foundation Trust and the ...

Japan had 254.8 cases of ulcerative colitis and 77 cases of Crohn's per 100,000 people, and a new study shows that the cases ...